Literature DB >> 6093353

Restriction of cell surface expression of Sendai virus hemagglutinin-neuraminidase glycoprotein correlates with its higher instability in persistently and standard plus defective interfering virus infected BHK-21 cells.

L Roux, P Beffy, A Portner.   

Abstract

To gain an understanding of the mechanism(s) by which Sendai virus generates a persistent infection, the expression of the hemagglutinin-neuraminidase (HN) and fusion (Fo) glycoproteins at the surfaces of BHK-21 cells infected with standard virus, a mixture of standard and defective interfering (DI) particles (mixed virus infection), and during persistent infection was investigated. The expression of HN and Fo was measured on the surfaces of infected cells by the binding of anti-HN and anti-Fo monoclonal antibodies. The results show that HN expression was restricted relative to Fo during mixed virus and persistent infections. The decreased levels of HN were investigated further by pulse-chase experiments which revealed that HN has an increased turnover rate in persistently infected cells and, to a lesser extent, in mixed virus infected cells. In analyzing the [35S]methionine-labeled protein composition of virus particles produced during the pulse-chase experiments, the increased turnover of newly synthesized HN was found to correlate with its decreased incorporation into virus particles. Interestingly, the poor HN incorporation also correlates with less efficient incorporation of the matrix M protein into virus particles.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093353     DOI: 10.1016/0042-6822(84)90152-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Characterization of human parainfluenza virus type 3 persistent infection in cell culture.

Authors:  A Moscona; M S Galinski
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Immunoglobulin A monoclonal antibodies protect against Sendai virus.

Authors:  M B Mazanec; J G Nedrud; M E Lamm
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins.

Authors:  G Mottet; A Portner; L Roux
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

4.  Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA.

Authors:  R G Paterson; S W Hiebert; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

5.  Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line.

Authors:  R Cattaneo; A Schmid; M A Billeter; R D Sheppard; S A Udem
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

6.  Defective Viral Genomes Alter How Sendai Virus Interacts with Cellular Trafficking Machinery, Leading to Heterogeneity in the Production of Viral Particles among Infected Cells.

Authors:  Emmanuelle Genoyer; Carolina B López
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

7.  Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus.

Authors:  T C Wong; M Ayata; S Ueda; A Hirano
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Persistent infections with Sendai virus and Newcastle disease viruses.

Authors:  P Lawton; Z Karimi; L Mancinelli; J T Seto
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different.

Authors:  A Hirano; A H Wang; A F Gombart; T C Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

10.  High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system.

Authors:  G Alkhatib; D J Briedis
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.